Cartesian Therapeutics (RNAC) Institutional Ownership $11.97 -1.03 (-7.92%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$11.97 0.00 (0.00%) As of 04/15/2025 05:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Cartesian Therapeutics (NASDAQ:RNAC)CurrentInstitutional OwnershipPercentage86.95%Number ofInstitutional Buyers(last 12 months)35TotalInstitutional Inflows(last 12 months)$373.81MNumber ofInstitutional Sellers(last 12 months)11TotalInstitutional Outflows(last 12 months)$77.50M Get RNAC Insider Trade Alerts Want to know when executives and insiders are buying or selling Cartesian Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data RNAC Institutional Buying and Selling by Quarter Remove Ads Cartesian Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/8/2025 Rhumbline Advisers13,006$171K0.0%+27.5%0.050% 2/17/2025Two Sigma Investments LP11,812$212K0.0%-8.5%0.046% 2/17/2025MPM Bioimpact LLC721,139$12.92M1.8%+14.6%2.837% 2/17/2025Nuveen Asset Management LLC72,099$1.29M0.0%+197.8%0.284% 2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.5,786$104K0.0%+44.8%0.023% 2/17/2025Citadel Advisors LLC315,000$5.64M0.0%-16.2%1.239% 2/17/2025Bank of America Corp DE11,690$209K0.0%+54.4%0.046% 2/17/2025683 Capital Management LLC125,000$2.24M0.1%+65.7%0.492% 2/14/2025Northern Trust Corp95,030$1.70M0.0%+50.6%0.374% 2/14/2025Virtus ETF Advisers LLC3,533$63K0.0%N/A0.014% Get the Latest News and Ratings for RNAC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cartesian Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/14/2025MetLife Investment Management LLC6,667$119K0.0%N/A0.026% 2/13/2025Barclays PLC19,099$342K0.0%+64.5%0.075% 2/13/2025Renaissance Technologies LLC13,800$247K0.0%N/A0.054% 2/13/2025Wells Fargo & Company MN4,847$87K0.0%+112.7%0.019% 2/12/2025Geode Capital Management LLC221,257$3.96M0.0%+63.0%0.870% 2/12/2025JPMorgan Chase & Co.274,740$4.92M0.0%-11.1%1.081% 2/11/2025Corebridge Financial Inc.5,122$92K0.0%+32.6%0.020% 2/10/2025Erste Asset Management GmbH173,566$3.26M0.0%-93.6%0.683% 2/6/2025Charles Schwab Investment Management Inc.26,803$480K0.0%+40.7%0.105% 2/4/2025Bank of New York Mellon Corp19,407$348K0.0%+28.5%0.076% 1/31/2025New York State Common Retirement Fund3,902$70K0.0%-23.5%0.015% 1/30/2025 Rhumbline Advisers10,201$183K0.0%+10.0%0.040% 1/27/2025Mirae Asset Global Investments Co. Ltd.4,562$82K0.0%+22.8%0.018% 1/24/2025China Universal Asset Management Co. Ltd.5,389$97K0.0%N/A0.021% 12/26/2024JPMorgan Chase & Co.309,018$4.98M0.0%+0.9%1.216% 11/19/2024Barclays PLC11,611$188K0.0%+208.6%0.046% 11/16/2024Geode Capital Management LLC135,700$2.19M0.0%+2.1%0.534% 11/15/2024Barclays PLC11,611$188K0.0%+208.6%0.046% 11/15/2024State Street Corp157,495$2.54M0.0%+2.5%0.620% 11/15/2024Ikarian Capital LLC52,193$841K0.1%-78.5%0.205% 11/13/2024Great Point Partners LLC200,000$3.22M0.9%N/A0.787% 11/13/2024BNP Paribas Financial Markets1,651$27K0.0%+122.5%0.006% 11/13/2024FMR LLC2,851,830$45.97M0.0%+458.3%11.219% 10/23/2024Lake Street Advisors Group LLC15,822$255K0.0%-50.0%0.074% 9/16/2024Point72 DIFC Ltd1,725$47K0.0%N/A0.008% 9/16/2024Cubist Systematic Strategies LLC13,010$351K0.0%N/A0.061% 9/16/2024Point72 Asia Singapore Pte. Ltd.1,824$49K0.0%N/A0.009% 8/27/2024Logos Global Management LP90,000$2.43M0.2%N/A0.506% 8/15/2024Point72 Asia Singapore Pte. Ltd.1,824$49K0.0%N/A0.009% 8/14/2024Cubist Systematic Strategies LLC13,010$351K0.0%N/A0.061% Could this be the start of AI’s Second Wind? (Ad)We're living in unprecedented times. Most people think it's too late to get into AI right now … That the biggest profits are already off the table.If you have any kind of money in the stock market … Click here to learn more — before it's too late8/14/2024Point72 DIFC Ltd1,725$47K0.0%N/A0.008% 8/14/2024Marshall Wace LLP30,038$811K0.0%N/A0.140% 8/14/2024Logos Global Management LP90,000$2.43M0.2%N/A0.421% 8/9/2024Renaissance Technologies LLC17,052$461K0.0%-96.9%0.096% 8/6/2024Lake Street Advisors Group LLC31,644$855K0.0%N/A0.178% 8/1/2024 Rhumbline Advisers8,487$229K0.0%-93.5%0.048% 7/26/2024Bank of New York Mellon Corp19,916$538K0.0%-93.7%0.112% 7/22/2024Hall Laurie J Trustee1,759$48K0.0%-96.7%0.010% 5/17/2024Artal Group S.A.9,136,635$5.94M0.2%N/A171.098% 5/14/2024American International Group Inc.56,202$37K0.0%N/A1.052% 5/10/2024Vanguard Group Inc.6,315,113$4.11M0.0%N/A118.172% 5/7/2024SG Americas Securities LLC47,134$31K0.0%N/A0.883% 5/3/2024Delphi Financial Group Inc.660,852$430K0.3%N/A12.261% 5/1/2024BNP Paribas Financial Markets59,125$38K0.0%N/A1.097% 4/23/2024Hall Laurie J Trustee52,775$34K0.0%N/A0.979% (Data available from 1/1/2016 forward)Remove Ads RNAC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RNAC shares? During the previous two years, 40 institutional investors and hedge funds held shares of Cartesian Therapeutics. The most heavily invested institutionals were FMR LLC ($45.97M), MPM Bioimpact LLC ($12.92M), Artal Group S.A. ($5.94M), Citadel Advisors LLC ($5.64M), JPMorgan Chase & Co. ($4.92M), Vanguard Group Inc. ($4.11M), and Geode Capital Management LLC ($3.96M).Learn more on RNAC's institutional investors. What percentage of Cartesian Therapeutics stock is owned by institutional investors? 86.95% of Cartesian Therapeutics stock is owned by institutional investors. Learn more on RNAC's institutional investor holdings. Which institutional investors have been buying Cartesian Therapeutics stock? Of the 35 institutional investors that purchased Cartesian Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Artal Group S.A. ($9.14M), Vanguard Group Inc. ($6.32M), FMR LLC ($2.34M), Delphi Financial Group Inc. ($660.85K), Great Point Partners LLC ($200K), Logos Global Management LP ($180K), and MPM Bioimpact LLC ($91.72K). How much institutional buying is happening at Cartesian Therapeutics? Institutional investors have bought a total of 19,539,449 shares in the last 24 months. This purchase volume represents approximately $373.81M in transactions. Which Cartesian Therapeutics major shareholders have been selling company stock? Of the 11 institutional investors that sold Cartesian Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Erste Asset Management GmbH ($2.53M), Renaissance Technologies LLC ($536.55K), Bank of New York Mellon Corp ($297.41K), Ikarian Capital LLC ($190.18K), Rhumbline Advisers ($121.40K), Citadel Advisors LLC ($60.77K), and Hall Laurie J Trustee ($51.02K). How much institutional selling is happening at Cartesian Therapeutics? Institutional investors have sold a total of 3,836,709 shares in the last 24 months. This volume of shares sold represents approximately $77.50M in transactions. Related Companies OCUL Institutional Ownership IOVA Institutional Ownership SNDX Institutional Ownership WVE Institutional Ownership COLL Institutional Ownership ELVN Institutional Ownership DYN Institutional Ownership GPCR Institutional Ownership ETNB Institutional Ownership CMRX Institutional Ownership This page (NASDAQ:RNAC) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredThis story is about to go viralThis Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cartesian Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cartesian Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RNAC Stock Free RNAC Stock Alerts